LymPro's success requires a few guinea pigs (GPs;
Post# of 30028
Revenue from Lympro will surely follow the growing number of GPs signing up. With the promise of revenue the market will not be as worried about dilution as we develop Eltoprazine, ESS, and the many MANF indications.
LymPro has the legitimacy of VALIDATION from both Beckton Dickenson and ICON and is now open for business, something the other AD blood tests are at least a couple years away from achieving.
If the pharmas Gerald is negotiating with regarding Lympro begin seeing these guinea pigs start lining up in greater and greater numbers.....they will become much more generous in their offers.
Gerald is now in the cat bird seat! Each week that goes by Lympro gains momentum and critical mass. The ball has started rolling now. It won't take long before it's impossible to stop!!